mbiome
Probiotics & PrebioticsEvidence briefing

Probiotics: What the Evidence Actually Says

Probiotics are a billion-pound industry, but which strains have genuine clinical evidence behind them? We break down the research by condition and strain.

By the mbiome editorial team7 min readPublished 4 April 2026
At a glance
Reading time
7 min
Last updated
4 Apr 2026
Probiotics: What the Evidence Actually Says

The global probiotics market is projected to exceed £65 billion by 2028. Yet the gap between marketing claims and clinical evidence remains significant. Here's what rigorous research actually supports.

What Are Probiotics?

The WHO defines probiotics as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." The key words are "adequate amounts" and "health benefit" — not all live bacteria qualify, and the benefits are strain-specific.

Strain Specificity Matters

This is the single most important concept in probiotics: benefits are specific to individual strains, not species or genera. Lactobacillus rhamnosus GG has strong evidence for certain conditions, but another Lactobacillus rhamnosus strain may have none. Product labels that list only the species without the strain identifier are a red flag. For a detailed breakdown by strain, see our probiotic strain guide.

What the Evidence Supports

Strong Evidence: - Antibiotic-associated diarrhoea — Saccharomyces boulardii and Lactobacillus rhamnosus GG have consistent evidence for reducing incidence when taken alongside antibiotics (Cochrane Review, 2017) - Acute infectious diarrhoea in children — L. rhamnosus GG and S. boulardii reduce duration by approximately 1 day (WHO recommendation) - Necrotising enterocolitis in preterm infants — Multiple strain combinations show significant reduction in incidence in NICU settings

Moderate Evidence: - IBS symptom management — Bifidobacterium infantis 35624 and certain multi-strain preparations show benefit for bloating and overall symptoms, but responses are highly individual - Ulcerative colitis maintenance — VSL#3 (now Visbiome) has evidence for maintaining remission alongside standard therapy - Vaginal health — Certain Lactobacillus crispatus strains show promise for reducing recurrent bacterial vaginosis

Limited or Preliminary Evidence: - General immune boosting - Weight loss - Mental health improvement - Skin conditions - Allergy prevention

What to Look for in a Probiotic

If you choose to take a probiotic, look for: 1. Named strains — not just genus and species 2. CFU count guaranteed at expiry — not just at manufacture 3. Evidence for your specific condition — a probiotic for IBS won't help with UTIs 4. Proper storage — many strains require refrigeration 5. Third-party testing — independent verification of contents

The Bottom Line

Probiotics are not a universal health solution. They have genuine, evidence-based applications for specific conditions, but the majority of commercial products make claims that outstrip the science. The most important thing is matching the right strain to the right condition at the right dose. If you are considering purchasing a probiotic, see our UK buying guide and our reviews of the best UK products. For IBS specifically, see our dedicated guide to probiotics for IBS.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, starting supplements, or making decisions about your health.

Reference layer

Key Terms

Glossary terms mentioned in this article

IBS (Irritable Bowel Syndrome)

A chronic functional gastrointestinal disorder characterised by abdominal pain, bloating, and altered bowel habits without identifiable structural cause. The microbiome is increasingly recognised as a contributing factor, with IBS patients typically showing reduced microbial diversity and altered bacterial composition compared to healthy controls.

Lactobacillus rhamnosus

One of the most extensively studied probiotic species. The strain L. rhamnosus GG has strong evidence for preventing antibiotic-associated diarrhoea and acute gastroenteritis in children. The strain L. rhamnosus JB-1 has shown anxiolytic effects in animal models via the vagus nerve, though human trials have been less conclusive.

Bifidobacterium

A genus of beneficial bacteria that dominates the infant gut and remains important throughout life. Various species (B. longum, B. infantis, B. breve) are among the most studied probiotics, with evidence for IBS, immunity, and infant health.

Lactobacillus

A genus of lactic acid-producing bacteria found naturally in the gut, mouth, and vaginal tract. Certain strains (L. rhamnosus GG, L. plantarum 299v) have strong clinical evidence for specific health benefits. Now reclassified into multiple genera including Lacticaseibacillus and Limosilactobacillus.

Probiotic

Live microorganisms which, when administered in adequate amounts, confer a health benefit on the host. Benefits are strain-specific, not species-wide.

CFU

Colony-Forming Units. The standard measure of viable (living) bacteria in a probiotic product. A count of 1 billion CFU means approximately 1 billion live organisms capable of replicating.

Medical disclaimer: The information on mbiome is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet or health routine.